Back to Anacor Homepage Developing Drug Candidates Through Boron Chemistry
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
Learn more about boron technology
Pipeline

Utilizing our boron chemistry platform, we have discovered and advanced into clinical development several novel and proprietary boron-based product candidates that address attractive market opportunities.

[ View pipeline ]

 
Pipeline Graphic
 
 
New Releases

Monday, June 29, 2015 | Anacor Pharmaceuticals Announces Amendment to KERYDIN Commercialization Agreement
Monday, June 1, 2015 | Anacor Pharmaceuticals Names Graeme Bell as New Executive Vice President and Chief Financial Officer
Wednesday, May 27, 2015 | Anacor Pharmaceuticals to Present at Upcoming Investor Conferences
 
New Releases Graphic